Previously, the authors investigated the effects of an ovarian somatic cell-specific dominant active allele of the HH signal transducer, referred to as SMOM2, using an AMHR2-driven CRE recombinase (Amhr2 cre/þ SmoM2) [13] . While these mice were infertile, they did have follicles that developed to the antral follicle stage. However, ovulation did not occur, resulting in trapped oocytes. The theca cells of the follicles lacked smooth muscle actin. Surprisingly, expression of downstream HH signal target genes was not affected by overexpression of HH. This led the authors to propose that the overactivation of HH must affect some earlier process.
Here, the authors examine earlier effects of HH pathway overactivation in the developing mouse ovary [3] . During embryonic development, oocytes develop in interconnected clusters or cysts [14] . The oocyte cysts break apart and become enclosed in primordial follicles perinatally [15] . Some primordial follicles are activated right away while others remain dormant until adulthood. Using RT-PCR, the authors show that normally Dhh and Ihh increase in the ovary around the time of birth while Shh remains low. HH target genes Gli1, Gli2, Ptch1, and Hhip are upregulated between Days 2 and 4, while in Amhr2 cre/þ SmoM2 mutants, these genes were prematurely upregulated. While normally expressed in the ovarian cortex where the majority of oocytes reside, HH target genes were upregulated in the medullary region in the Amhr2 cre/þ SmoM2 ovaries. The overexpression of HH signaling caused an increase in degenerating oocytes during follicle formation, leading to a reduction in the number of primordial follicles in prepubertal mice. Follicle abnormalities were also observed with the first wave of follicles that developed, including secondary follicles with abnormal granulosa cells and follicles containing more than one oocyte. The multiple oocyte follicles suggest that HH overexpression may also affect primordial follicle formation.
To follow up on their previous finding that the theca layer of preovulatory follicles in adult ovaries lacked smooth muscle actin [13] , the authors demonstrate that blood vessels in the theca layer were deficient in vascular smooth muscle. To determine if this was caused by HH effects earlier in the progression of the follicle, a microarray analysis on 2-day-old wild-type and mutant ovaries was undertaken. This analysis revealed that genes involved in vascular and tube development were upregulated. In addition, the neonatal ovaries had more capillaries. How this observation relates to the later effects in the preovulatory follicles is not known, and the relationship between the smooth muscle actin deficiency and the anovulation phenotype is unclear and warrants further study.
Several observations in the HH-overexpressing mice lead the authors to suggest that adrenal precursor cells are missorted to the ovary in these animals. First, SHH, as well as HHsignaling target genes, are upregulated in the medullary region of the ovary starting at 17.5 days post coitum. Adrenal and gonadal cells arise from a common precursor [8] . The adrenal cells express SHH [16] , and SHH-positive cells in the ovary of mutants may be adrenal precursor cells. Supporting this concept, microarray analysis of mutants revealed upregulation of steroidogenic genes that would normally be expressed in the adrenal gland [17] . Another study used the same dominant active allele of SMO but with SF1-driven CRE recombinase and also found cells in the ovary expressing a steroidogenic enzyme CYP17A, indicating that they may also be mistargeted adrenal cells [18] .
Many questions remain regarding HH signaling in the mammalian ovary. In particular, how do the early effects caused by overexpression of HH signaling in the ovarian somatic cells lead to the adult phenotype? What is the importance of vasculature development in growing follicles? Is initial primordial follicle formation affected? Are the SHHpositive cells in the ovary missorted adrenal cell precursors? In addition, the effects of loss of HH signaling will need to be determined using tissue-specific knockouts as most pathway mutants are embryonic lethal. Ren and colleagues [3] provide a framework for follow-up studies that can address these questions.
FIG. 1. Diagram of Hedgehog signaling. A)
When the PTCH receptor is not bound by HH ligand, PTCH inhibits SMO and GLI transcription factors remain inactive in the cytoplasm. B) When HH binds to PTCH, SMO inhibition is relieved and signals to GLI. GLI is translocated to the nucleus where it activates target genes.
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